Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boshoff

Showing results (551-560 of 568) with videos related to

Pageof 57
Sort By:
Antimicrobial Agents and Chemotherapy|May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis TreatmentEric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Journal of the American Chemical Society|January 5, 2023
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal InhibitionTimm O Koller, Ullrich Scheid, Teresa Kösel, et al.
ACS Infectious Diseases|April 6, 2024
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential LiabilitiesHelena I M Boshoff, Katherine Young, Yong-Mo Ahn, et al.
ACS Infectious Diseases|March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion CharacterizationDinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Nature Medicine|January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosisBrendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Cell|November 3, 2018
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic DesignYin Yao Dong, Hua Wang, Ashley C W Pike, et al.
Nature Immunology|October 21, 2010
A model for harmonizing flow cytometry in clinical trialsHolden T Maecker, J Philip McCoy, , et al.
Journal of Thrombosis and Haemostasis : JTH|May 25, 2023
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trialPrapa Kanagaratnam, Darrel P Francis, Daniel Chamie, et al.
Journal of Medicinal Chemistry|November 18, 2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification StudiesColin R Wilson, Richard K Gessner, Atica Moosa, et al.
Nature Biotechnology|October 22, 2013
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencingGarrett M Frampton, Alex Fichtenholtz, Geoff A Otto, et al.
Pageof 57

Showing results (551-560 of 568) with videos related to

Sort By:
Pageof 57
Antimicrobial Agents and Chemotherapy|May 24, 2022
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective <i>In Vivo</i> with the Potential To Shorten Tuberculosis TreatmentEric L Nuermberger, Maria Santos Martínez-Martínez, Olalla Sanz, et al.
Journal of the American Chemical Society|January 5, 2023
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal InhibitionTimm O Koller, Ullrich Scheid, Teresa Kösel, et al.
ACS Infectious Diseases|April 6, 2024
Mtb-Selective 5-Aminomethyl Oxazolidinone Prodrugs: Robust Potency and Potential LiabilitiesHelena I M Boshoff, Katherine Young, Yong-Mo Ahn, et al.
ACS Infectious Diseases|March 10, 2018
2-Mercapto-Quinazolinones as Inhibitors of Type II NADH Dehydrogenase and Mycobacterium tuberculosis: Structure-Activity Relationships, Mechanism of Action and Absorption, Distribution, Metabolism, and Excretion CharacterizationDinakaran Murugesan, Peter C Ray, Tracy Bayliss, et al.
Nature Medicine|January 13, 2026
Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosisBrendan M Crowley, Helena I Boshoff, Aidan Boving, et al.
Cell|November 3, 2018
Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic DesignYin Yao Dong, Hua Wang, Ashley C W Pike, et al.
Nature Immunology|October 21, 2010
A model for harmonizing flow cytometry in clinical trialsHolden T Maecker, J Philip McCoy, , et al.
Journal of Thrombosis and Haemostasis : JTH|May 25, 2023
A randomized controlled trial to investigate the use of acute coronary syndrome therapy in patients hospitalized with COVID-19: the COVID-19 Acute Coronary Syndrome trialPrapa Kanagaratnam, Darrel P Francis, Daniel Chamie, et al.
Journal of Medicinal Chemistry|November 18, 2017
Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification StudiesColin R Wilson, Richard K Gessner, Atica Moosa, et al.
Nature Biotechnology|October 22, 2013
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencingGarrett M Frampton, Alex Fichtenholtz, Geoff A Otto, et al.
Pageof 57